SOTERA HEALTH COMPANY (SHC) EBITDA
- 2024-09-30: Basis Reported; EBITDA (m); Operating income $80.51M; Depreciation and amortization (m).
- 2024-06-30: Basis Reported; EBITDA (m); Operating income $76.80M; Depreciation and amortization (m).
- 2024-03-31: Basis Reported; EBITDA (m); Operating income $53.17M; Depreciation and amortization (m).
- 2023-09-30: Basis Reported; EBITDA (m); Operating income $76.10M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2024-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2024-09-30 | Reported | (m) | $80.51M | (m) | $285.47M | (m) | $36.39M* | $97.45M* | (m) | (m) | $62.01M | $25.76M |
|---|
| 2024-06-30 | Reported | (m) | $76.80M | (m) | $276.59M | (m) | $41.92M* | $61.30M* | (m) | (m) | $60.58M | $6.39M |
|---|
| 2024-03-31 | Reported | (m) | $53.17M | (m) | $248.18M | (m) | $34.89M | $9.70M | (m) | (m) | $58.21M | $4.69M |
|---|
| 2023-09-30 | Reported | (m) | $76.10M | (m) | $263.18M | (m) | $52.02M* | $41.85M* | (m) | (m) | $54.11M | $14.13M |
|---|
| 2023-06-30 | Reported | (m) | $63.20M | (m) | $255.28M | (m) | $53.13M* | -$336.57M* | (m) | (m) | $60.29M | $10.97M |
|---|
| 2023-03-31 | Reported | (m) | $33.37M | (m) | $220.59M | (m) | $45.00M | $33.87M | (m) | (m) | $61.91M | $2.56M |
|---|
| 2022-09-30 | Reported | (m) | $63.20M | (m) | $248.70M | (m) | $39.00M* | $67.78M* | (m) | (m) | $57.09M | $16.93M |
|---|
| 2022-06-30 | Reported | (m) | $71.50M | (m) | $266.64M | (m) | $36.10M* | $58.29M* | (m) | (m) | $63.13M | $17.69M |
|---|
| 2022-03-31 | Reported | (m) | $53.49M | (m) | $236.75M | (m) | $35.55M | $49.97M | (m) | (m) | $59.54M | $14.63M |
|---|
| 2021-09-30 | Reported | (m) | $65.67M | (m) | $226.16M | (m) | $16.11M* | $80.94M* | (m) | (m) | $44.04M | $13.66M |
|---|
| 2021-06-30 | Reported | (m) | $78.27M | (m) | $251.92M | (m) | $23.85M* | $78.10M* | (m) | (m) | $49.83M | $19.18M |
|---|
| 2021-03-31 | Reported | (m) | $46.36M | (m) | $212.15M | (m) | $20.94M | $56.16M | (m) | (m) | $52.47M | $3.02M |
|---|
| 2020-09-30 | Reported | (m) | $47.03M | (m) | $200.03M | (m) | $10.20M* | $46.05M* | (m) | (m) | $45.63M | -$1.21M |
|---|
| 2020-06-30 | Reported | (m) | $61.74M | (m) | $213.09M | (m) | $10.45M* | $47.00M* | (m) | (m) | $42.68M | $3.77M |
|---|
| 2020-03-31 | Reported | (m) | $44.87M | (m) | $188.20M | (m) | $12.99M | $5.69M | (m) | (m) | $37.05M | -$12.23M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | (m) | $94.90M | $1.16B | (m) | $138.02M | $287.19M | (m) | (m) | $252.76M | $69.56M |
|---|
| 2024-12-31 | Reported | $381.93M | (m) | (m) | (m) | (m) | $179.07M | $224.16M | (m) | (m) | $242.63M | $69.48M |
|---|
| 2023-12-31 | Reported | $353.29M | (m) | (m) | (m) | (m) | $214.97M | -$147.73M | (m) | (m) | $236.67M | $54.65M |
|---|
| 2022-12-31 | Reported | $312.65M | (m) | (m) | (m) | (m) | $182.38M | $277.96M | (m) | (m) | $245.71M | -$9.54M |
|---|
| 2021-12-31 | Reported | $320.93M | (m) | (m) | (m) | (m) | $102.16M | $281.55M | (m) | (m) | $198.16M | $58.59M |
|---|
| 2020-12-31 | Reported | $269.32M | (m) | (m) | (m) | (m) | $53.51M | $120.58M | (m) | (m) | $178.53M | -$1.37M |
|---|
| 2019-12-31 | Reported | $250.3M | (m) | (m) | (m) | (m) | $57.26M | $149.04M | (m) | (m) | $147.48M | $19.51M |
|---|